Close

Presentation

The HEMOTION Trial
SessionClinical Trials Platform Session
DescriptionThis presentation will focus on the results of the HEMOTION Trial and discuss the best evidence on transfusion thresholds in critically ill patients with TBI and how to apply these evidence at bedside.
Speaker
Alexis Turgeon
CHU de Québec – Université Laval
Event Type
General Session
TimeTuesday, October 15th10:30am - 10:48am PDT
LocationHarbor Ballrooms D-I
Focus Areas
Traumatic Brain Injury
Target Audiences
Advanced
Next PresentationNext Presentation
The ExTINGUISH Trial: A Phase-2B randomized placebo-controlled trial of inebilizumab in anti-NMDA receptor encephalitis